Zhu Hongbing Trims BAYZED HEALTH Stake with HK$5.82 Million Share Sale

Stock News

Aug 31

Hong Kong stock exchange filings show that on August 27, Zhu Hongbing sold 1.8396 million shares of BAYZED HEALTH (02609) at an average price of HK$3.1612 per share, totaling approximately HK$5.8153 million.

Following the transaction, Zhu's latest shareholding stands at around 78.5634 million shares, representing a 5.96% stake in the company. The deal involves related parties including Cui Yifan, Shanghai Xukun Enterprise Management Co., Ltd., and Shanghai Xuxi Enterprise Management Partnership (Limited Partnership).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1199948118"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1199948118\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1199948118?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-31 19:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199948118","market":"fut","top_or_hot":-1,"title":"Zhu Hongbing Trims BAYZED HEALTH Stake with HK$5.82 Million Share Sale","media":"Stock News","content":"<p>Hong Kong stock exchange filings show that on August 27, Zhu Hongbing sold 1.8396 million shares of <b>BAYZED HEALTH</b> (02609) at an average price of HK$3.1612 per share, totaling approximately HK$5.8153 million.<br><br>Following the transaction, Zhu's latest shareholding stands at around 78.5634 million shares, representing a 5.96% stake in the company. The deal involves related parties including Cui Yifan, Shanghai Xukun Enterprise Management Co., Ltd., and Shanghai Xuxi Enterprise Management Partnership (Limited Partnership).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zhu Hongbing Trims BAYZED HEALTH Stake with HK$5.82 Million Share Sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZhu Hongbing Trims BAYZED HEALTH Stake with HK$5.82 Million Share Sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-31 19:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong stock exchange filings show that on August 27, Zhu Hongbing sold 1.8396 million shares of <b>BAYZED HEALTH</b> (02609) at an average price of HK$3.1612 per share, totaling approximately HK$5.8153 million.<br><br>Following the transaction, Zhu's latest shareholding stands at around 78.5634 million shares, representing a 5.96% stake in the company. The deal involves related parties including Cui Yifan, Shanghai Xukun Enterprise Management Co., Ltd., and Shanghai Xuxi Enterprise Management Partnership (Limited Partnership).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02609","symbol_name":"佰泽医疗","start_time":0,"source_url":"","article_id":"1199948118","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199948118","pubTimestamp":1788174988,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Hong Kong stock exchange filings show that on August 27, Zhu Hongbing sold 1.8396 million shares of BAYZED HEALTH (02609) at an average price of HK$3.1612 per share, totaling approximately HK$5.8153...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02609":"佰泽医疗","EWH":"香港ETF-iShares MSCI","BK1209":"保健护理机构"},"translate_title":"朱红兵以582万港元出售股份减持百泽健康股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02609":1,"EWH":1},"content_text":"Hong Kong stock exchange filings show that on August 27, Zhu Hongbing sold 1.8396 million shares of BAYZED HEALTH (02609) at an average price of HK$3.1612 per share, totaling approximately HK$5.8153 million.Following the transaction, Zhu's latest shareholding stands at around 78.5634 million shares, representing a 5.96% stake in the company. The deal involves related parties including Cui Yifan, Shanghai Xukun Enterprise Management Co., Ltd., and Shanghai Xuxi Enterprise Management Partnership (Limited Partnership).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}